← Back to Screener
Black Hawk Acquisition Corporation Units (BKHAU)
Price$11.69
Favorite Metrics
Price vs S&P 500 (26W)1.69%
Price vs S&P 500 (4W)-2.21%
Market Capitalization$48.26M
P/E Ratio (Annual)36.30x
All Metrics
Book Value / Share (Quarterly)$2.24
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.07
Price vs S&P 500 (YTD)2.86%
EPS (TTM)$0.16
10-Day Avg Trading Volume0.00M
EPS Excl Extra (TTM)$0.16
EPS (Annual)$0.19
ROI (Annual)6.46%
Cash / Share (Quarterly)$0.00
P/E Basic Excl Extra (TTM)36.30x
P/E Normalized (Annual)36.30x
ROA (Last FY)5.57%
EBITD / Share (TTM)$-0.13
Cash Flow / Share (Annual)$-0.07
P/B Ratio2.42x
P/B Ratio (Quarterly)2.33x
ROA (TTM)2.75%
EPS Growth QoQ (YoY)-74.42%
EPS Incl Extra (Annual)$0.19
Current Ratio (Annual)0.03x
Quick Ratio (Quarterly)0.03x
3-Month Avg Trading Volume0.00M
52-Week Price Return10.35%
P/E Incl Extra (TTM)36.30x
52-Week High$11.95
EPS Excl Extra (Annual)$0.19
26-Week Price Return3.84%
Quick Ratio (Annual)0.03x
13-Week Price Return3.20%
Total Debt / Equity (Annual)0.03x
Current Ratio (Quarterly)0.03x
Enterprise Value$48.82
Cash / Share (Annual)$0.00
3-Month Return Std Dev12.26%
ROE (Last FY)6.65%
EPS Basic Excl Extra (Annual)$0.19
Total Debt / Equity (Quarterly)0.03x
EPS Incl Extra (TTM)$0.16
ROI (TTM)2.92%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-20.44%
P/E Ratio (TTM)36.30x
EPS Growth TTM (YoY)-23.68%
Year-to-Date Return3.29%
5-Day Price Return0.26%
EPS Normalized (Annual)$0.19
Month-to-Date Return0.26%
EBITD / Share (Annual)$-0.13
P/E Excl Extra (TTM)36.30x
EPS Basic Excl Extra (TTM)$0.16
P/B Ratio (Annual)2.33x
Book Value / Share (Annual)$2.24
Price vs S&P 500 (13W)3.69%
Beta0.03x
Revenue / Share (TTM)$0.00
ROE (TTM)2.94%
52-Week Low$10.53
Industry Peers — Biological Products(89)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
BKHAUBlack Hawk Acquisition Corporation Units | — | — | — | — | $11.69 |
AMGNAmgen Inc | 5.20x | 9.95% | 73.30% | 2.93% | $350.16 |
GILDGilead Sciences Inc | 5.71x | 2.40% | 78.83% | 133.64% | $135.87 |
ARGXargenx SE American Depositary Shares | 12.59x | 89.56% | 150.91% | — | $834.45 |
BNTXBioNTech SE American Depositary Share | 9.06x | -11.81% | 84.21% | — | $105.19 |
BIIBBiogen Inc. Common Stock | 2.72x | 2.22% | 75.69% | -18.77% | $183.34 |
MRNAModerna, Inc. Common Stock | 10.91x | -39.93% | 70.32% | — | $54.59 |
NBIXNeurocrine Biosciences Inc | 4.64x | 21.45% | 98.18% | 2.31% | $131.59 |
EXELExelixis Inc | 4.89x | 6.85% | 96.39% | 31.10% | $43.61 |
TECHBio-Techne Corp. | 7.72x | 1.64% | 66.60% | -20.58% | $60.58 |
IBRXImmunityBio, Inc. Common Stock | 74.42x | 668.31% | 99.34% | — | $8.20 |
About
Black Hawk Acquisition Corp is a blank check company formed to identify and complete a business combination with an operating company. The company has not yet selected a target acquisition. As with all blank check companies, this represents a speculative investment with the outcome dependent upon successful completion of a merger or acquisition.